Why Challenge Trials of SARS‐CoV‐2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events

Ethics & Human Research
Volume 42, Issue 4 Pages: 1-40 July–August 2020
https://onlinelibrary.wiley.com/toc/25782363/current

Why Challenge Trials of SARS‐CoV‐2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events
Nir Eyal

 

Pages: 24-34
First Published: 22 May 2020